Home
Conditions
Myelodysplastic Syndromes

Clinical trial condition

Myelodysplastic Syndromes

Explore clinical trials studying Myelodysplastic Syndromes. Study availability and eligibility vary by location and protocol.

700 public trials 123 recruiting studies

Refine in advanced search Browse all conditions

Myelodysplastic Syndromes trial results

Completed

Cytarabine and UCN-01 in Treating Patients With Refractory or Relapsed Acute Myelogenous Leukemia or Myelodysplastic Syndrome

NCT00004263

Conditions: Anemia, Anemia, Refractory, Anemia, Refractory, with Excess of Blasts, +9 more
Locations: Arthur G. James Cancer Hospital - Ohio State University Columbus, Ohio, United States

University of Texas - MD Anderson Cancer Center Houston, Texas, United States

View Trial Details

Completed

Peripheral Stem Cell Transplantation Plus Filgrastim in Treating Patients With Acute or Chronic Myelogenous Leukemia

NCT00002833

Conditions: Anemia, Anemia, Refractory, Anemia, Refractory, with Excess of Blasts, +26 more
Locations: University of Texas - MD Anderson Cancer Center Houston, Texas, United States

View Trial Details

Completed

Decitabine and Peripheral Stem Cell Transplantation in Treating Patients Who Have Relapsed Following Bone Marrow Transplantation for Leukemia, Myelodysplastic Syndrome, or Chronic Myelogenous Leukemia

NCT00002832

Conditions: Blast Crisis, Bone Marrow Diseases, Carcinogenesis, +23 more
Locations: University of Texas - MD Anderson Cancer Center Houston, Texas, United States

View Trial Details

Completed

Donor Stem Cell Transplant After Busulfan, Fludarabine, and Antithymocyte Globulin in Treating Patients With Hematologic Cancer or Myelodysplastic Syndrome

NCT00732316

Conditions: Anemia, Anemia, Refractory, Anemia, Refractory, with Excess of Blasts, +30 more
Locations: Asan Medical Center - University of Ulsan College of Medicine Seoul, South Korea

View Trial Details

Completed

Infliximab in Treating Patients With Myelodysplastic Syndrome

NCT00074074

Conditions: Anemia, Anemia, Refractory, Anemia, Refractory, with Excess of Blasts, +4 more
Locations: AZ Sint-Jan Bruges, Belgium

Institut Jules Bordet Brussels, Belgium

Hopital Universitaire Erasme Brussels, Belgium

Universitair Ziekenhuis Antwerpen Edegem, Belgium

View all 19 locations

View Trial Details

Completed

Idarubicin, Cytarabine, and Gemtuzumab Ozogamicin in Treating Patients With Previously Untreated High-Risk Myelodysplastic Syndrome or Acute Myeloid Leukemia Secondary to Myelodysplastic Syndrome

NCT00077116

Conditions: Anemia, Anemia, Refractory, Anemia, Refractory, with Excess of Blasts, +16 more
Locations: AZ Sint-Jan Bruges, Belgium

Institut Jules Bordet Brussels, Belgium

Cliniques Universitaires Saint-Luc Brussels, Belgium

H. Hartziekenhuis - Roeselaere. Roeselare, Belgium

View Trial Details

Completed

Busulfan and Cyclophosphamide Followed by Bone Marrow Transplantation in Treating Patients With Acute Myelogenous Leukemia or Myelodysplastic Syndrome

NCT00004896

Conditions: Anemia, Anemia, Refractory, Anemia, Refractory, with Excess of Blasts, +25 more
Locations: Robert H. Lurie Comprehensive Cancer Center at Northwestern University Chicago, Illinois, United States

View Trial Details

Completed

Chemotherapy Plus Bone Marrow Transplantation and Filgrastim in Treating Patients With Acute Myelogenous Leukemia or Myelodysplastic Syndrome

NCT00004899

Conditions: Bone Marrow Diseases, Chronic Disease, Congenital Abnormalities, +20 more
Locations: Robert H. Lurie Comprehensive Cancer Center at Northwestern University Chicago, Illinois, United States

View Trial Details

Completed

Stem Cell Transplantation in Treating Patients With Hematologic Cancer

NCT00004904

Conditions: Amyloidosis, Blast Crisis, Blood Coagulation Disorders, +87 more
Locations: Robert H. Lurie Comprehensive Cancer Center, Northwestern University Chicago, Illinois, United States

View Trial Details

Completed

Bone Marrow and Peripheral Stem Cell Transplantation in Treating Patients With Hematologic Cancer

NCT00004232

Conditions: Amyloidosis, Blast Crisis, Blood Coagulation Disorders, +87 more
Locations: Robert H. Lurie Comprehensive Cancer Center, Northwestern University Chicago, Illinois, United States

View Trial Details

Myelodysplastic Syndromes

Myelodysplastic Syndromes trial results

Related conditions